Your support fuels our research to #EndALS! Donate Now


TDI 186

This small molecule is being tested by scientists at the ALS Therapy Development Institute for its potential to help support the unfolded protein response in ALS patients by specifically targeting the SOD1 protein. 


Type: Small Molecule
Stage: Preclinical
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

This is a complex approach which has proved unsuccessful in the past; however, we hope to show our current construct effective in cell-based tests quickly.

Comment on this Topic

(All comments are moderated before they appear here.)